Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Secondary CNS involvement in patients with systemic lymphoma (SCNSL)
Secondary CNS lymphoma: Skull, dura, leptomeninges > > parenchymal mass
Best diagnostic clue: Diffusely enhancing dural mass ± bone involvement
May see leptomeningeal enhancement or nonsupression of cerebrospinal fluid on FLAIR; CT hyperdensity
Lower relative cerebral blood volume than other tumors
Meningioma
Meningeal metastases
Primary CNS lymphoma
“Tumefactive” demyelinating disease (MS, ADEM)
Prognostic markers suggestive of CNS relapse
Elevated serum lactate dehydrogenase levels
Presence of B symptoms
Extranodal involvement at > 1 site
Advanced stage
Aggressive histologic features increase risk for SCNSL
Involvement of liver, bladder, testis, or adrenals also increases risk of CNS spread
CNS involvement of lymphoma almost always fatal
Prophylactic CNS chemotherapy recommended for patients considered at high risk of CNS recurrence
Occult lymphoma found in 8% of patients presenting with CNS lymphoma
SCNSL commonly mimics meningioma or other metastatic disease
Secondary CNS lymphoma (SCNSL)
Secondary involvement of CNS in patients with systemic lymphoma
Best diagnostic clue
Enhancing dural mass ± bone involvement
Location
Typically involves dura or leptomeninges
Parenchymal lesions may occur
Peripheral nerve = neurolymphomatosis
Spine involvement: ~ 3-5%
Morphology
Solitary mass or multiple lesions
May be circumscribed or infiltrative
Become a Clinical Tree membership for Full access and enjoy Unlimited articles
If you are a member. Log in here